Navicare Biotech Co., Ltd.’s (8472) Moving Averages Convergence Divergence (MACD) indicator is -4.62, suggesting Navicare Biotech Co., Ltd. is a Buy.
Navicare Biotech Co., Ltd.’s (8472) 20-Day exponential moving average is TWD 61.83, while Navicare Biotech Co., Ltd.’s (8472) share price is TWD 49.00, making it a Sell.
Navicare Biotech Co., Ltd.’s (8472) 50-Day exponential moving average is TWD 66.91, while Navicare Biotech Co., Ltd.’s (8472) share price is TWD 49.00, making it a Sell.
Navicare Biotech Co., Ltd.’s (8472) 10-Day exponential moving average is TWD 57.69, while Navicare Biotech Co., Ltd.’s (8472) share price is TWD 49.00, making it a Sell.
Navicare Biotech Co., Ltd.’s (8472) 100-Day exponential moving average is TWD 69.88, while Navicare Biotech Co., Ltd.’s (8472) share price is TWD 49.00, making it a Sell.
Navicare Biotech Co., Ltd.’s (8472) stock price is TWD 49.00 and Navicare Biotech Co., Ltd.’s (8472) 50-day simple moving average is TWD 68.73, creating a Sell signal.
Navicare Biotech Co., Ltd.’s (8472) stock price is TWD 49.00 and Navicare Biotech Co., Ltd.’s (8472) 100-day simple moving average is TWD 72.53, creating a Sell signal.
Navicare Biotech Co., Ltd.’s (8472) stock price is TWD 49.00 and Navicare Biotech Co., Ltd.’s (8472) 200-day simple moving average is TWD 71.74, creating a Sell signal.